Keywords
MedicineRanibizumabMacular degenerationTolerabilityOphthalmologyBevacizumabSurgeryInternal medicineAdverse effectChemotherapy
Affiliated Institutions
Related Publications
Age-related macular degeneration
Age-related macular degeneration is a leading cause of visual impairment and severe vision loss. Clinically, it is classified as early-stage (medium-sized drusen and retinal pig...
Photodynamic therapy for circumscribed choroidal haemangioma
ABSTRACT. Purpose: To assess the efficacy of photodynamic therapy (PDT) as a new treatment for circumscribed choroidal haemangioma (CCH). Methods: Eight patients with CCH were t...
The epidemiology of age related eye diseases in Asia
In the past decade, several large population based studies have provided new information on the prevalence of visual impairment and the major age related eye diseases in Asia. T...
Artificial Intelligence and Deep Learning in Ophthalmology
Artificial intelligence (AI) based on deep learning (DL) has sparked tremendous global interest in recent years. DL has been widely adopted in image recognition, speech recognit...
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study
Many causes of vision impairment can be prevented or treated. With an ageing global population, the demands for eye health services are increasing. We estimated the prevalence a...
Publication Info
- Year
- 2006
- Type
- article
- Volume
- 113
- Issue
- 4
- Pages
- 623-632.e1
- Citations
- 188
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
188
OpenAlex
12
Influential
142
CrossRef
Cite This
Philip J. Rosenfeld,
Jeffrey S. Heier,
Gary Hantsbarger
et al.
(2006).
Tolerability and Efficacy of Multiple Escalating Doses of Ranibizumab (Lucentis) for Neovascular Age-Related Macular Degeneration.
Ophthalmology
, 113
(4)
, 623-632.e1.
https://doi.org/10.1016/j.ophtha.2006.01.027
Identifiers
- DOI
- 10.1016/j.ophtha.2006.01.027
- PMID
- 16581423